Holen Sie sich die Stockscreener-App
6.37
3.92%
-0.26
Handel nachbörslich:
6.37
Schlusskurs vom Vortag:
$6.63
Offen:
$6.61
24-Stunden-Volumen:
17,283
Relative Volume:
0.75
Marktkapitalisierung:
$57.62M
Einnahmen:
$27.64M
Nettoeinkommen (Verlust:
$-1.04M
KGV:
-56.02
EPS:
-0.1137
Netto-Cashflow:
$2.48M
1W Leistung:
-3.48%
1M Leistung:
-3.48%
6M Leistung:
+7.60%
1J Leistung:
+30.27%
1-Tages-Spanne:
$6.33
$6.6999
1-Wochen-Bereich:
$6.2601
$6.6999
52-Wochen-Spanne:
$4.52
$7.60
Immucell Corp Stock (ICCC) Company Profile
Firmenname
Immucell Corp
Sektor
Branche
Telefon
(207) 878-2770
Adresse
56 EVERGREEN DR, PORTLAND, ME
Compare ICCC vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ICCC
Immucell Corp
|
6.37 | 59.97M | 27.64M | -1.04M | 2.48M | -0.1137 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 121.46B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.93B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.87B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 42.07B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.65B | 5.36B | 287.73M | 924.18M | 2.5229 |
Immucell Corp Aktie (ICCC) Neueste Nachrichten
ICCC SEC FilingsImmucell 10-K, 10-Q, 8-K Forms - Stock Titan
ImmuCell Corp (ICCC) Q4 2025 Earnings Call Highlights: Navigating Growth Amidst Challenges By GuruFocus - Investing.com Canada
ImmuCell 2025 Net Loss Narrows Y/Y as Sales & Margins Improve - Yahoo Finance
ImmuCell Corporation (NASDAQ:ICCC) Q4 2025 Earnings Call Transcript - Insider Monkey
ImmuCell Q4 Earnings Call Highlights - Yahoo Finance
Earnings call transcript: ImmuCell’s Q4 2025 shows growth despite challenges - Investing.com
ImmuCell Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
ImmuCell Corporation Reports Improved Financial Results for 2025 with Increased Net Operating Income and Revenue Growth - Quiver Quantitative
ImmuCell (Nasdaq: ICCC) lifts 2025 EBITDA and narrows annual net loss - Stock Titan
ImmuCell Corporation (NASDAQ:ICCC) Sees Significant Growth in Short Interest - MarketBeat
ImmuCell Corporation to Announce Unaudited Financial Results for Q4 and Year-End 2025 on March 4, 2026 - Quiver Quantitative
ImmuCell (NASDAQ:ICCC) Stock Price Crosses Above 200-Day Moving Average – What’s Next? - Defense World
Does ImmuCell Corporation have a sustainable dividendJuly 2025 WrapUp & Stepwise Entry/Exit Trade Alerts - mfd.ru
Why retail investors pile into ImmuCell Corporation stockJuly 2025 Big Picture & Low Risk Investment Opportunities - mfd.ru
Will ImmuCell Corporation benefit from AI trendsBear Alert & Weekly Momentum Stock Picks - mfd.ru
ImmuCell directors to step down at 2026 annual meeting, board changes expected By Investing.com - Investing.com South Africa
ImmuCell directors to step down at 2026 annual meeting, board changes expected - Investing.com
Two ImmuCell (ICCC) directors to step down after 2026 shareholder meeting - Stock Titan
ImmuCell announces new executive employment agreements and option grants By Investing.com - Investing.com South Africa
ImmuCell announces new executive employment agreements and option grants - Investing.com
Aug Intraday: Is ImmuCell Corporation forming a bullish divergence2025 Technical Patterns & Daily Volume Surge Trade Alerts - baoquankhu1.vn
ImmuCell (NASDAQ:ICCC) Stock Price Passes Above 200 Day Moving AverageWhat's Next? - MarketBeat
ImmuCell Corporation (NASDAQ:ICCC) Short Interest Update - MarketBeat
Those who invested in ImmuCell (NASDAQ:ICCC) a year ago are up 25% - Yahoo Finance
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement - Investing.com
Is ImmuCell Corporation stock resilient to inflationQuarterly Trade Summary & Precise Trade Entry Recommendations - Улправда
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense - Investing.com
Calf health company pauses one treatment to ramp a fast-growing product - Stock Titan
Macro Review: Is ImmuCell Corporation stock near bottom after declineJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - Улправда
How rising interest rates impact ImmuCell Corporation stockCPI Data & Daily Market Momentum Tracking - ulpravda.ru
Will ImmuCell Corporation stock maintain dividend yieldJuly 2025 Short Interest & Trade Opportunity Analysis Reports - ulpravda.ru
ImmuCell Corporation Announces Investor Conference Call to Discuss Strategic Shift and Q4 2025 Sales Results - Quiver Quantitative
Cattle firm ImmuCell shifts focus to calf product, previews 2025 sales - Stock Titan
Head-To-Head Survey: Abbott Laboratories (NYSE:ABT) versus ImmuCell (NASDAQ:ICCC) - Defense World
The Christmas party is still ongoing in these stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - MSN
The Christmas Party Is Still Ongoing In These Stocks: Nvidia, Sidus Space, Coupang, Vanda Pharmaceuticals, ImmuCell - Asianet Newsable
ImmuCell Puts Re-Tain On Pause After FDA Letter - Benzinga
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio - sharewise.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Top Stock Reports for AbbVie, Coca-Cola & Chevron - sharewise.com
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain By Investing.com - Investing.com South Africa
ImmuCell shifts focus to First Defense after FDA setback for Re-Tain - Investing.com
ImmuCell Corporation Receives Incomplete FDA Letter for Re-Tain® NADA and Expands First Defense® Sales Force by 50% - Quiver Quantitative
How a $900M calf-health market is reshaping this Maine animal company - Stock Titan
Will ImmuCell Corporation stock outperform Dow Jones indexJuly 2025 Big Picture & Free Weekly Chart Analysis and Trade Guides - Улправда
Why ImmuCell Corporation stock is popular among millennialsQuarterly Market Review & Long-Term Capital Growth Strategies - Улправда
Can ImmuCell Corporation stock maintain operating marginsPortfolio Growth Summary & High Return Trade Guides - ulpravda.ru
ImmuCell Corporation's (NASDAQ:ICCC) Price Is Right But Growth Is Lacking After Shares Rocket 34% - simplywall.st
ImmuCell (NASDAQ:ICCC) Stock Passes Below 200-Day Moving AverageWhat's Next? - MarketBeat
ImmuCell (NASDAQ:ICCC) delivers shareholders 27% return over 1 year, surging 13% in the last week alone - simplywall.st
Finanzdaten der Immucell Corp-Aktie (ICCC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):